Made available in DSpace on 2021-06-25T15:08:07Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01; AbbVie; Introduction and objectives: Glecaprevir/pibrentasvir is a highly effective and well tolerated treatment for hepatitis C infection. Brazilian patients were not included in the original development studies for glecaprevir/pibrentasvir. This study aimed to assess safety and efficacy of glecaprevir...
Texto completo. Acesso restrito. p. 700–708; Submitted by Santiago Fabio (fabio.ssantiago@hotmail.com) on 2013-10-09T18:43:26Z No. of bitstreams: 1 3333.pdf: 353833 bytes, checksum: dec6effec957eb30783b421ac6047738 (MD5); Approved for entry into archive by Rodrigo Meirelles (rodrigomei@ufba.br) on 2013-11-03T14:24:32Z (GMT) No. of bitstreams: 1 3333.pdf: 353833 bytes, checksum: dec6effec957eb30783b421ac6047738 ...